New corona vaccine in development Agreed on final-stage trial in Brazil 10:11 on June 9
k10012463571_202006090913_202006090922.mp4
The Brazilian government of South America has announced that it has agreed to carry out a final-stage trial from next week on 2,000 people in the largest cities such as Sao Paulo for a new coronavirus vaccine being developed by Oxford University in the United Kingdom.
This vaccine is being developed by Oxford University as a pharmaceutical giant'AstraZeneca' headquartered in the United Kingdom, and it has already been conducted up to the second stage clinical trial to inoculate hundreds of people and check the safety and effect ..
By the 8th, the Brazilian government will carry out the final stage 3 trial of this vaccine under development in Brazil to inoculate more humans to confirm its safety and efficacy over a long period of time. Announced that they have agreed with the side.
Specifically, from next week, it will start vaccination of 2,000 people including medical personnel in Sao Paulo and Rio de Janeiro, the largest cities.
In Brazil, the number of people infected with the new coronavirus is the second highest after the United States, and the infection is spreading, and the government says that acceptance of vaccine trials will lead to faster infection control.
Although the pharmaceutical company may not be successful in developing this vaccine, it is planning to prepare a mass production system, and the US Biomedical Advanced Research and Development Agency has also supported more than $1 billion (more than JPY 108 billion in Japanese yen). I will.